PATH

Showing 21-40 of 115 topics
can the whole world read our email correspondence? breast cancer screening 11/25/12
EMA workshop on clinical trial data and transparency 22 Nov 2012: a landmark meeting Richard Lehman 11/23/12
our email list is open, no password needed breast cancer screening 11/25/12
How the UK drug regulator looks at access to data, and EMA meeting 22 Nov breast cancer screening 11/24/12
BMJ blog about yesterday's EMA workshop on sharing clinical trial data TGr...@bmj.com 11/23/12
Fwd: EMA press release: Workshop kicks off process towards proactive publication of clinical trial data (ID:humtop) Peter Doshi 11/23/12
The Tamiflu story on multimedia jeffer...@gmail.com 11/19/12
European governments should sue the drug firm Roche breast cancer screening 11/13/12
Re: Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data Ash Paul 11/11/12
European governments should sue Roche for Tamiflu losses breast cancer screening 11/8/12
Canada's Clinical Trial Infrastructure: A Prescription for Improved Access to New Medicines Ash Paul 11/4/12
Tamiflu open data campaign jeffer...@gmail.com 11/3/12
Re: Medtronic Helped Write, Edit Positive 'Infuse' Spine Studies Ash Paul 10/30/12
IOM Workshop on Sharing Clinical Research Data Marilyn Mann 10/12/12
Re: Glaxo Opens Door to Data on Research Ash Paul 10/11/12
Missing data undermine clinical trials Ash Paul 10/11/12
Re: Misconduct Widespread in Retracted Science Papers Ash Paul 10/2/12
Re: Restoring Faith In Pharma Studies Ash Paul 10/1/12
Ben Goldacre's BAD PHARMA Richard Lehman 9/29/12
Scientific Data Should Be Shared: An Open Letter to the Australian Research Council Ash Paul 9/29/12
More topics »